Dr. Reddy's Laboratories Limited RDY
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.21% | -71.68% | -86.94% | -18.82% | 9.84% |
| Total Depreciation and Amortization | -4.72% | 2.08% | 15.84% | 4.75% | 21.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 152.42% | -70.50% | -35.11% | 163.15% | -316.88% |
| Change in Net Operating Assets | -256.54% | -32.62% | 1,072.36% | 20.14% | 68.50% |
| Cash from Operations | -69.01% | -105.74% | -32.71% | 56.24% | 60.39% |
| Capital Expenditure | 58.03% | 54.79% | 43.97% | 11.66% | 33.50% |
| Sale of Property, Plant, and Equipment | 437.25% | 907.41% | 1,585.71% | -91.45% | -49.98% |
| Cash Acquisitions | -- | -- | -80.18% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 224.37% | 152.15% | -351.31% | -309.69% | -110.71% |
| Cash from Investing | 140.96% | 118.10% | -88.40% | -78.80% | 51.99% |
| Total Debt Issued | -- | -- | 275.99% | 391.02% | -84.67% |
| Total Debt Repaid | 209.62% | -1,685.58% | -62.45% | 5.88% | 45.06% |
| Issuance of Common Stock | -26.09% | 26.53% | 618.18% | 20.00% | -33.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 8.59% | -- | -- | -- | 4.10% |
| Other Financing Activities | -10.07% | -35.08% | -46.57% | 2.09% | -118.34% |
| Cash from Financing | -29.88% | -435.67% | 190.36% | 1,149.86% | -131.62% |
| Foreign Exchange rate Adjustments | -101.41% | -80.05% | 106.52% | 6,888.51% | 913.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.62% | 32.46% | -299.33% | 374.97% | -86.42% |